Worldwide Clinical Trials
Mark Reed is a seasoned financial professional with extensive experience in financial planning and analysis. Currently serving as the Senior Director of Global FP&A at Worldwide Clinical Trials since November 2021, Mark previously held the position of Director of Global FP&A. Prior experience includes over 13 years at Spok, where Mark worked as Senior Director of Financial Planning and Analysis and Senior Director of Revenue Accounting and Analysis. Mark also contributed to USA Mobility in various roles from Director of Revenue Accounting and Analysis to Financial Analyst, and began a career at KPMG as a Consultant. Mark holds a Bachelor of Arts in Finance from JMU College of Business, earned between 1993 and 1997.
This person is not in any teams
This person is not in any offices
Worldwide Clinical Trials
11 followers
About Worldwide Clinical Trials Worldwide Clinical Trials is a leading full-service global contract research organization (CRO) that works in partnership with biotechnology and pharmaceutical companies to create customized solutions that advance new treatments. Our capabilities include bioanalytical laboratory services, Phase I-IV clinical trials, and post-approval and real-world evidence studies – all powered by our team members who bring their expertise and a collaborative, personalized approach to each clinical program. Anchored in our company’s scientific heritage, our dedicated therapeutic focus on cardiovascular, metabolic, neuroscience, oncology, and rare diseases, is applied to develop flexible plans and solve problems quickly for our customers. Our talented team of 3,000+ professionals spans 60+ countries, and embraces a culture of diversity, equity, inclusion, and belonging (DEI&B). We are united in cause with our customers to improve the lives of patients through new, innovative therapies. For more information on Worldwide, visit www.Worldwide.com.